OS Therapies Incorporated

NYSEAM:OSTX Stock Report

Market Cap: US$84.6m

OS Therapies Management

Management criteria checks 3/4

OS Therapies' CEO is Paul Romness, appointed in Apr 2018, has a tenure of 6.33 years. total yearly compensation is $360.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 11.21% of the company’s shares, worth $9.49M. The average tenure of the management team and the board of directors is 1.6 years and 3.7 years respectively.

Key information

Paul Romness

Chief executive officer

US$360.0k

Total compensation

CEO salary percentage100.0%
CEO tenure6.3yrs
CEO ownership11.2%
Management average tenure1.6yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Paul Romness's remuneration changed compared to OS Therapies's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$360kUS$360k

-US$8m

Sep 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$360kUS$360k

-US$6m

Sep 30 2022n/an/a

-US$6m

Dec 31 2021US$360kUS$360k

-US$8m

Compensation vs Market: Paul's total compensation ($USD360.00K) is below average for companies of similar size in the US market ($USD691.65K).

Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.


CEO

Paul Romness (58 yo)

6.3yrs

Tenure

US$360,000

Compensation

Mr. Paul A. Romness, MPH, is Founder, President, Chief Executive Officer and Director of OS Therapies Inc. since April 2018. Prior to founding OS Therapies Inc., Mr. Romness served as a Principal for PR St...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Romness
Founder6.3yrsUS$360.00k11.21%
$ 9.5m
Robert Petit
Chief Medical Officer & Chief Scientific Officer4.9yrsUS$300.00k1.0%
$ 844.0k
Christopher Acevedo
Chief Financial Officer1.1yrsno data0.50%
$ 422.0k
Jack Doll
Chief of Staff1.6yrsno datano data
Gerald Commissiong
Chief Business Officerless than a yearno datano data

1.6yrs

Average Tenure

59.5yo

Average Age

Experienced Management: OSTX's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Paul Romness
Founder6.3yrsUS$360.00k11.21%
$ 9.5m
Colin Goddard
Non Executive Chairman of the Board3.7yrsUS$5.04k0.13%
$ 110.8k
Peter Anderson
Member of Scientific Advisory Boardno datano datano data
John Ciccio
Independent Director3.7yrsUS$40.000.10%
$ 84.4k
Theodore Search
Independent Director3.7yrsUS$40.000.10%
$ 84.4k
Joacim Borg
Independent Director2.1yrsUS$40.00no data
Olivia Egge
Member of Patient Advocacy Advisory Boardno datano datano data
Nabil Ahmed
Member of Scientific Advisory Boardno datano datano data
Doug Hawkins
Member of Scientific & Medical Advisory Boardno datano datano data
Meenakshi Hegde
Member of Scientific & Medical Advisory Boardno datano datano data
Alejandro Sweet-Cordero
Member of Scientific & Medical Advisory Boardno datano datano data
Brenda Weigel
Member of Scientific & Medical Advisory Boardno datano datano data

3.7yrs

Average Tenure

44yo

Average Age

Experienced Board: OSTX's board of directors are considered experienced (3.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.